Hajek, Roman Minarik, Jiri Straub, Jan Pour, Ludek and Jungova, Alexandra Berdeja, Jesus G. Boccadoro, Mario and Brozova, Lucie Spencer, Andrew van Rhee, Frits Vela-Ojeda, Jorge Thompson, Michael A. Abonour, Rafat Chari, Ajai and Cook, Gordon Costello, Caitlin L. Davies, Faith E. Hungria, Vania T. M. Lee, Hans C. Leleu, Xavier Puig, Noemi and Rifkin, Robert M. Terpos, Evangelos Usmani, Saad Z. Weisel, Katja C. Zonder, Jeffrey A. Barinova, Magda Kuhn, Matyas and Silar, Jiri Capkova, Lenka Galvez, Kenny Lu, Jin Skacel, Tomas Elliott, Jennifer Demers, Brittany Marie, Dawn and Ren, Kaili Maisnar, Vladimir, Closing the Efficacy and Effectiveness Gap: Outcomes in
Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with
Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice
Remain Comparable to the Outcomes Reported in the Phase 3 Tourmaline-MM1
Study, Blood advances, (134), 2019, AMER SOC HEMATOLOGY,